Loading company details...
Latest Form 4 (Nov 3, 2026): Todd Alfred Carter (Chief Scientific Officer): Grant/Award of 33,000 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 3, 2026 | Todd Alfred Carter, Chief Scientific Officer | Grant/Award | 33,000 | n/a |
| Nov 3, 2026 | Robin Swartz, President | Grant/Award | 68,250 | n/a |
| Jun 11, 2026 | George A. Scangos | Grant/Award | 30,000 | n/a |
| Jun 11, 2026 | Catherine J. Mackey | Grant/Award | 30,000 | n/a |
| Jun 11, 2026 | Steven Hyman | Grant/Award | 30,000 | n/a |
| Jun 11, 2026 | Nancy Vitale | Grant/Award | 30,000 | n/a |
| Jun 11, 2026 | Michael J. Higgins | Grant/Award | 30,000 | n/a |
| Jun 11, 2026 | Jude Onyia | Grant/Award | 30,000 | n/a |
| Jun 11, 2026 | James A. Geraghty | Grant/Award | 30,000 | n/a |
| Jun 11, 2026 | Grace Colon | Grant/Award | 30,000 | n/a |